AWIQLI
AWIQLI
Approved
DIN Number
02546213
Drug Class
Human
Market Date
Jun 13, 2024
Company
HC
Novo Nordisk Canada Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02546213
AIG Number0165803001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
A10AE07 INSULIN ICODEC
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification68:20.08
Health Canada Classification
ACTIVE INGREDIENTS (1)
INSULIN ICODECActive
Strength: 1050 UNIT / 1.5 ML
Monograph: INSULIN ICODEC